Enrolling by invitation NCT04123457
Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Lymphedema. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Biorepository for Discovery and Validation of Biomarkers for Optimization of Microvascular Treatment of Lymphedema
Overview
Researchers are collecting information, saliva, blood and tissue from subjects with lymphedema to store for future research.
Primary outcome measures
- Biospecimen Acquisition [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- Adult (18+ years of age)
- Ability to provide written consent
- Has been diagnosed with Lymphedema
Exclusion criteria
- Under the age of 18 years old
- Inability to provide written consent
- Previous lymphovenous bypass or lymph node transfer surgery
- Major changes occur to co-morbid conditions
- Proven ICG or iodine allergy
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
United States · 1 center
- Mayo Clinic in Florida — Jacksonville
Identifiers
NCT: NCT04123457 · 18-006576